In addition, pan PPAR-iMSC-EVs stimulated the PI3K-AKT pathway in steatotic human primary hepatocytes, and a higher number of proliferating hepatic cells were observed in pan PPAR-iMSC-EVs-treated NASH mice. The gene discussed is AKT1; the disease is metabolic dysfunction-associated steatohepatitis.